Brian G Hunt
Affiliations: | 2022 | Cancer Biology | University of Cincinnati, Cincinnati, OH |
Google:
"Brian Hunt"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hunt BG, Davis JC, Fox LH, et al. (2023) RON-augmented cholesterol biosynthesis in breast cancer metastatic progression and recurrence. Oncogene |
| Hunt BG, Fox LH, Davis JC, et al. (2023) An Introduction and Overview of RON Receptor Tyrosine Kinase Signaling. Genes. 14 |
| Vicente-Muñoz S, Hunt BG, Lange TE, et al. (2022) NMR-based metabolomic analysis identifies RON-DEK-β-catenin dependent metabolic pathways and a gene signature that stratifies breast cancer patient survival. Plos One. 17: e0274128 |
| Brown NE, Jones A, Hunt BG, et al. (2022) Prostate tumor RON receptor signaling mediates macrophage recruitment to drive androgen deprivation therapy resistance through Gas6-mediated Axl and RON signaling. The Prostate |
| Hunt BG, Jones A, Lester C, et al. (2022) RON () and HGFL () Co-Overexpression Supports Breast Tumorigenesis through Autocrine and Paracrine Cellular Crosstalk. Cancers. 14 |
| Ruiz-Torres SJ, Bourn JR, Benight NM, et al. (2021) Macrophage-mediated RON signaling supports breast cancer growth and progression through modulation of IL-35. Oncogene |
| Borcherding DC, Hugo ER, Fox SR, et al. (2021) Suppression of Breast Cancer by Small Molecules That Block the Prolactin Receptor. Cancers. 13 |
| Bourn JR, Ruiz-Torres SJ, Hunt BG, et al. (2021) Tumor cell intrinsic RON signaling suppresses innate immune responses in breast cancer through inhibition of IRAK4 signaling. Cancer Letters. 503: 75-90 |
| Wicker CA, Hunt BG, Krishnan S, et al. (2021) Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma models. Cancer Letters |
| Hunt BG, Wicker CA, Bourn JR, et al. (2020) MST1R (RON) expression is a novel prognostic biomarker for metastatic progression in breast cancer patients. Breast Cancer Research and Treatment |